BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 7562561)

  • 1. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM; Nitecki DE; Biancalana S; Feldman RI
    Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.
    Orbuch M; Taylor JE; Coy DH; Mrozinski JE; Mantey SA; Battey JF; Moreau JP; Jensen RT
    Mol Pharmacol; 1993 Oct; 44(4):841-50. PubMed ID: 7901752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
    Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
    Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    Eur J Pharmacol; 1995 Dec; 294(1):55-69. PubMed ID: 8788416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of two distinct receptors for mammalian bombesin-like peptides.
    Battey J; Wada E; Corjay M; Way J; Fathi Z; Shapira H; Harkins R; Wu J; Slattery T; Mann E
    J Natl Cancer Inst Monogr; 1992; (13):141-4. PubMed ID: 1327030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368.
    Ryan RR; Katsuno T; Mantey SA; Pradhan TK; Weber HC; Coy DH; Battey JF; Jensen RT
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1202-11. PubMed ID: 10454496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior.
    Bédard T; Mountney C; Kent P; Anisman H; Merali Z
    Behav Brain Res; 2007 Apr; 179(1):133-40. PubMed ID: 17335915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
    Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
    Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-peptide bombesin receptor antagonists, kuwanon G and H, isolated from mulberry.
    Mihara S; Hara M; Nakamura M; Sakurawi K; Tokura K; Fujimoto M; Fukai T; Nomura T
    Biochem Biophys Res Commun; 1995 Aug; 213(2):594-9. PubMed ID: 7646517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
    Mantey SA; Coy DH; Entsuah LK; Jensen RT
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM; Hoang DO; Feldman RI
    Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bombesin-like peptide receptor subtypes promote mitogenesis, which requires persistent receptor signaling.
    Feldman RI; Bartholdi MF; Wu JM
    Mol Pharmacol; 1996 Nov; 50(5):1346-54. PubMed ID: 8913367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bombesin family peptides and antagonists on guinea pig nasal mucosal secretion.
    Ali M; Gawin AZ; Baraniuk JN
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1266-71. PubMed ID: 8786559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of cloned human bombesin receptors.
    Benya RV; Kusui T; Pradhan TK; Battey JF; Jensen RT
    Mol Pharmacol; 1995 Jan; 47(1):10-20. PubMed ID: 7838118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S; Spindel ER; Rubin NH; Singh P
    Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells.
    Frucht H; Gazdar AF; Park JA; Oie H; Jensen RT
    Cancer Res; 1992 Mar; 52(5):1114-22. PubMed ID: 1310640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
    Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
    Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP.
    Benya RV; Fathi Z; Kusui T; Pradhan T; Battey JF; Jensen RT
    Mol Pharmacol; 1994 Aug; 46(2):235-45. PubMed ID: 8078487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.